• Kyodo News

  • SHARE

Hepatitis C patients and Nihon Pharmaceutical Co. reached a deal Sunday to end a series of damages suits over tainted blood products that infected the patients with a hepatitis virus.

Signing the agreement, Tsutomu Miura, Nihon Pharmaceutical president, told the patients, “I sincerely apologize to you that we could not prevent the outbreak and spread of damage. As a drug maker we are deeply reflecting on this in order to support patients and protect people’s lives.”

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)